MODULATION OF THE MDR PHENOTYPE IN DOXORUBICIN-RESISTANT MCF7 BREAST-CARCINOMA CELLS USING TERFENADINE AND KETOCONAZOLE

Authors
MURPHY MP OWEN R BERNSTEIN LA SCHMIDT KH
Citation
Mp. Murphy et al., MODULATION OF THE MDR PHENOTYPE IN DOXORUBICIN-RESISTANT MCF7 BREAST-CARCINOMA CELLS USING TERFENADINE AND KETOCONAZOLE, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 174-174
Citations number
NO
Categorie Soggetti
Pharmacology & Pharmacy
Journal title
Clinical pharmacology and therapeutics → ACNP
ISSN journal
00099236
Volume
57
Issue
2
Year of publication
1995
Pages
174 - 174
Database
ISI
SICI code
0009-9236(1995)57:2<174:MOTMPI>2.0.ZU;2-V